Clinical Trials
4 trialsNCT00019097 2024-03-04
Vaccine Therapy in Treating Patients With Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00000105 2017-11-29
Vaccination With Tetanus and KLH to Assess Immune Responses.
Masonic Cancer Center, University of Minnesota
Terminated
NCT02745756 2017-08-30
A Combined Cell Therapy Approach to the Treatment of Neuroblastoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Withdrawn
NCT00091676 2012-02-03
BiovaxID
Biovest International
Phase 3 Unknown